Amisulpiride Dosing and Titration in Schizophrenia

Recommended Dosing Strategies

The American College of Psychiatry recommends starting amisulpiride at 400-800 mg/day for acute exacerbations with predominantly positive symptoms, with evidence supporting 800 mg/day from the first day for optimal response 1
For negative symptoms, the National Institute of Mental Health suggests low-dose amisulpride at 50 mg twice daily (100 mg/day total) when positive symptoms are well controlled or not a primary concern 2, 1
The therapeutic range of 400-1200 mg/day shows efficacy comparable to haloperidol, risperidone, and flupenthixol for positive symptoms, with a recommended maximum dose of up to 1200 mg/day if needed 1

The American Psychiatric Association recommends increasing amisulpiride dose to 800 mg/day within the first week based on response, with flexible dose adjustments after week 4-6 based on clinical response 1
When switching to amisulpiride, a gradual cross-titration over approximately 4 weeks is recommended rather than abrupt switching to avoid symptom destabilization, with a suggested protocol of reducing prior antipsychotic by 25-50% while starting amisulpiride at target dose 1

The European Psychiatric Association suggests allowing a minimum of 4 weeks at therapeutic dose before declaring treatment failure, with significant symptom improvement expected by week 4-6 2, 1
Response can be defined as ≥30% reduction in PANSS total scores from baseline, and if inadequate response after 4 weeks at therapeutic dose with confirmed adherence, consider switching to an antipsychotic with different pharmacodynamic profile 2